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Abstract
Background: Mortality associated with aortic graft infection is considerable. The gold standard for surgical
treatment remains explantation of the graft. However, prognostic factors associated with early mortality due to this
surgical procedure are not well-known.
Methods: Retrospective analysis of patients admitted in our center between January 2006 and October 2011 for
aortic graft infection. The primary endpoint was in-hospital mortality. A bivariate analysis of characteristics of
patients associated with in-hospital outcome was performed.
Results: Twenty five evaluable patients were studied. All patients were male. Their mean age was 67 ± 8.4 years.
Most of them (92%) had severe underlying diseases. An in situ prosthetic graft replacement, mainly using
cryopreserved arterial allografts, was performed in all patients, excepted one who underwent extra-anatomic bypass.
Causative organisms were identified in 23 patients (92%). The in-hospital mortality rate was 48%. Among
pre-operative characteristics, age ≥ 70 years, creatinine ≥ 12 mg/L and C reactive protein ≥ 50 mg/L were
significantly associated with in-hospital mortality. Hospital mortality rates increased with the number of risk factor
present on ICU admission, and were 0%, 14.3%, 85.7% and 100% for 0, 1, 2 and 3 factors, respectively. The only
intra-operative factor associated with prognosis was an associated intestinal procedure due to aorto-enteric fistula.
SAPS II, SOFA score and occurrence of medical or surgical complications were postoperative characteristics
associated with in-hospital mortality.
Conclusion: Morbidity and mortality associated with surgical approach of aortic graft infections are considerable.
Age and values of creatinine and C Reactive protein on hospital admission appear as the most important
determinant of in hospital mortality. They could be taken into account for guiding the surgical strategy.
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Background
Infection represents one of the major complications as-
sociated with prosthetic aortic graft with a reported inci-
dence ranging 0.5% to 2% [1]. It be could lower as
demonstrated by Vogel et al. [2]. They studied 12,626
patients who underwent, between 1987 and 2005, open
repair for abdominal aortic aneurysms. The 2-year rate
of aortic graft infection was 0.19%. The occurrence of
bacteremia or surgical site infection during the index
hospitalization was significantly associated with the de-
velopment of aortic graft infection.
The optimal management of aortic graft infection re-
mains unclear and many questions on diagnosis, surgical
management, and antibiotic therapy are unresolved [3]. For
example, if the gold standard for surgical treatment is al-
ways graft explantation, the best techniques for reperfusion
are unknown. The extra-anatomic bypassing technique
using an axillofemoral graft was long considered the tech-
nique associated with the lower re-infection rate. It now ap-
pears than in situ revascularisation procedure could be
more effective [4,5]. Nevertheless, uncertainty remains
about the best graft for in situ replacement. The choice be-
tween normal graft, silver-coated polyester graft, rifampin-
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impregnated graft, allografts or autogenous vein could be
difficult [3,4].
Aortic graft infection is associated with considerable mor-
tality and morbidity. In the Vogel et al. study, in-hospital
mortality rate for patients readmitted for infection was 18%
[2]. However, recent studies reported higher mortality rates
[6]. To the best of our knowledge only a few studies re-
ported factors associated with prognosis of patients suffer-
ing from aortic graft infection. We created in 2005 a
multidisciplinary group including vascular surgeons, micro-
biologists, infectious diseases physicians, anesthesiologists
and intensivists to optimize the management of patients
with prosthetic vascular graft infection. This group has
been managing a growing number of patients from public
and private hospitals of the Nord-Pas de Calais area (4 mil-
lions of inhabitants), in the north of France. We reported in
2012 our experience about the first 85 evaluable patients
treated in our center between 2005 and 2009 [7]. Given the
lack of prognostic data about in-hospital outcome of pa-
tients suffering from aortic graft infection, our goal was to
identify preoperative, intraoperative and postoperative char-
acteristics of patients associated with poor outcome.
Methods
Study population
All patients admitted from January 2006 to October 2011
in the Intensive Care Unit (ICU), and the infectious dis-
eases and surgical vascular departments of Tourcoing Hos-
pital with a diagnosis of intra abdominal aortic graft
infection were included in this retrospective study. In ac-
cordance with French law, approval of an Ethics Committee
was not required for a cohort study that did not modify
existing diagnosis or therapeutic strategies.
All patients had a previous aortofemoral or aortoiliac
bypass. They were considered to suffer from definite
intra abdominal aortic graft infection if at least two of
the three following criteria were present: (a) clinical
signs of infection either systemic (fever, chills, septic
shock) or in the area of the prosthesis (i.e., enteric aortic
fistula, intra-operative gross purulence, failure of graft
incorporation), (b) biological signs of infection (C-react-
ive protein > 10 mg/l, white blood count > 10,000/mm3)
or radiological signs of infection (pathognomonic peri-
graft air or fluid, abscess) and (c) positive culture of in-
traoperative specimens or blood cultures (for potentially
‘contaminant’ pathogens such as coagulase-negative
Staphylococcus, P. acnes or corynebacteria at least two
intraoperative specimens or blood cultures or, at least
one intraoperative specimen and one blood culture are
required) [8].
Surgical procedures and antimicrobial management
All patients underwent a surgical procedure including
complete debridement of devitalized and infected tissues
around the prosthesis, total graft excision and in situ recon-
struction or extra-anatomic bypass grafting.
Blood specimens for culture were drawn from all fe-
brile patients (over 38.5°C). Bacterial samples were col-
lected intraoperatively. Multiple intraoperative samples
were cultured on blood agar plates with standard aerobic
and anaerobic methods. Antibiotic susceptibility pat-
terns were interpreted in accordance with recommenda-
tions of the Comité de l’Antibiogramme de la Société
Française de Microbiologie [9].
Empirical broad-spectrum intravenous antibiotic ther-
apy was started immediately after intra-operative sam-
pling and was secondarily adapted to microbiological
results. In case of severe sepsis or septic shock, empirical
therapy was started before surgical management, imme-
diately after blood samples had been collected. Initial
antimicrobial treatment was considered appropriate
when all causative pathogens were in vitro susceptible to
at least one of the antibiotics in the regimen. The dur-
ation of intravenous antimicrobial treatment was at least
6 weeks.
Data collection and definitions
On hospital admission, data about demographic charac-
teristics, underlying diseases, prior vascular procedures,
and biological findings were recorded.
Diabetes mellitus and chronic obstructive pulmonary
diseases (COPD) were defined according to criteria pro-
posed by the Expert Committee on the diagnosis and
classification of diabetes mellitus and the American
Thoracic Society, respectively [10,11]. A body mass
index (BMI) ≥ 30 Kg/m2 defined obesity [12]. Immuno-
suppression included transplant, cancer, acquired im-
munodeficiency syndrome, immunosuppressive drugs
and other immunodeficiency conditions. Risk of the sur-
gical procedure was evaluated by the POSSUM score
[13]. A classification of the preoperative physical status
(ASA score) of the American Society of Anaesthesiolo-
gist was used for anaesthetic risk prediction [14].
Data about surgical management and intra-operative
care were collected. They included type and duration of
surgery, duration of aortic clamping, volume of intra-
operative fluid administration and blood transfusion,
and use of vasopressors.
On ICU admission, the severity of illness was assessed
by the Simplified Acute Physiology score II (SAPS II),
and the Sequential Organ Failure Assessment (SOFA)
score [15,16].
During ICU stay, we recorded data about the use and
duration of mechanical ventilation, renal replacement
therapy, vasopressors, and occurrence of complications.
Septic shock, acute respiratory distress syndrome, acute
renal failure or hospital acquired infections were defined
according to usual criteria and categorized as medical
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complications. Vascular complications such as graft
thrombosis, bleeding, or distal embolization were cate-
gorized as surgical complications.
Outcome assessment
The primary outcome was the in-hospital mortality rate,
defined as any death, regardless of its cause, occurring
within the hospitalization in our center.
Statistical analysis
Descriptive analyses were performed to check and resume
data. Quantitative variables are reported as means ± SD.
Qualitative variables are reported as number and percen-
tage. Continuous variables were compared using Student’s
t test. When appropriate, continuous variables were
analyzed as categorical variables using cut-points deter-
mined by method of box plots. Categorical variables
were compared using the Chi-square test or Fisher’s
exact test when the Chi-square was not appropriate.
Differences between groups were considered significant
for variables yielding a p value ≤ 0.05. No multivariate
analysis was performed.
All statistical analyses were performed using SAS Soft-
ware, V9.1.
Results
During the study period, 26 patients suffering from
intra-abdominal aortic graft infection were admitted in
our institution. One patient was not included due to
missing data.
Main characteristics of patients on hospital admission
are summarized in Table 1. All patients were male and
most of them (96%) had severe underlying diseases such
as hypertension, coronary artery disease, COPD or obes-
ity. Infection occurred within the 4 months following
initial aortic graft surgery in 7 cases (28%). Four of the
25 patients were admitted in ICU before surgical
management.
Eight patients exhibiting on admission an anastomotic
rupture underwent an emergency surgical procedure,
one of whom died during surgery. The other 17 patients
had elective surgery. An in situ prosthetic graft replace-
ment was performed in all patients, excepted one who
underwent an extra-anatomic bypass. Implanted aortic
grafts were wrapped with omental flaps in 21 patients.
Cryopreserved arterial allografts were mainly used (n =
22/23). In 4 patients, with aorto-enteric fistula, an intes-
tinal procedure was required. Durations of operation
and aortic clamping, blood transfusions, colloid and
crystalloid administration volumes and use of vasopres-
sors are summarized in Table 2.
Causative organisms of aortic graft infection were
identified in 23 patients (92%). Preoperative blood cul-
tures were positive in 13 cases. In the remaining 10
cases, only bacterial cultures from intra-operative sam-
ples were positive. Thirty causative pathogens were iso-
lated. In 8 patients, more than one pathogen was
identified. Organisms were Gram positive cocci (methi-
cillin susceptible S. aureus n = 3, methicillin resistant S.
aureus n = 2, coagulase negative staphylococcus n = 3,
Streptococcus spp. n = 3, Enterococcus spp. n = 2), Gram
negative bacilli (E. coli n = 8; enterobacteriaceae n = 2),
Gram positive bacilli (n = 3), anaerobes (n = 2) and Can-
dida spp. (n = 2).
Table 1 Preoperative characteristics of patients
Variables
Age (years) 67 ± 8.4
Comorbidities
Obesity (BMI > 30 kg/m2) 11 (44%)
Hypertension 18 (72%)
Coronary artery disease 16 (64%)
Diabetes mellitus 4 (16%)
COPD 7 (28%)
Immunosuppression 6 (24%)
ASA Score≥ 3 21 (84%)
POSSUM score 46.1 ± 10.7
Preoperative severe sepsis 7 (28%)
Previous graft
Aortounifemoral bypass graft/Dacron 5 (20%)/5
Aortobifemoral bypass graft/Dacron 14 (56%)/13
Aortobiiliac bypass/Dacron 6 (24%)/6
Biological data
Creatinine (mg/L) 15.0 ± 13.8
C Reactive Protein (mg/L) 69.1 ± 76.1
Data are expressed as mean ± standard deviation values or numbers (%)
of patients.
Table 2 Intra-operative characteristics of patients
Variables
Mean duration of operation (minutes) 270 ± 81
Mean duration of aortic clamping (minutes) 118 ± 50
Suprarenal aortic clamping 6 (24%)
Associated intestinal procedure 4 (16%)
Blood transfusion
Packed red cells (number of patients/units) 25 (100%)/5.7 ± 2.1
Fresh frozen plasma (number of patients/units) 21 (84%)/3.2 ± 1.8
Platelets (number of patients) 4 (16%)
Volume of intra-operative colloid administration (ml) 1020 ± 549
Volume of intra-operative crystalloid administration (ml) 3740 ± 1280
Use of vasopressor(s) 20 (80%)
Data are expressed as mean ± standard deviation values or numbers (%)
of patients.
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Antimicrobial therapy was begun before surgical pro-
cedures in 17 cases (68%) because either preoperative
identification of causative organism(s) (n = 10) or pre-
operative presence of severe sepsis (n = 7). Most anti-
microbial regimens included a wide spectrum betalactam
(piperacillin-tazobactam n = 12, imipenem n = 4, 3rd gene-
ration cephalosporin n = 3) combined with an agent
effective against methicillin-resistant staphylococcus spp.
(glycopeptide n = 16, daptomycin n = 3, linezolid n = 1).
Initial antimicrobial therapy was considered adequate in
22 patients (96%).
After surgical procedures, 24 patients were admitted
in the ICU. Main data about severity scores, vasopres-
sors use, mechanical ventilation, and biological charac-
teristics on ICU admission are reported Table 3. During
ICU stay, 16 patients (67%) developed medical complica-
tions, acute renal failure (n = 13), septic shock (n = 11),
hospital-acquired infections (n = 5) and acute respiratory
distress syndrome (ARDS) (n = 2). Renal replacement
therapy was required for 12 (50%) patients. The num-
bers of days without mechanical ventilation, vaso-
pressors and/or renal replacement therapy on D28 for
patients requiring such treatments are reported Table 3.
Surgical complications occurred in 15 patients (63%).
Most frequent complications were bleeding (n = 8), graft
thrombosis (n = 5), distal embolization (n = 4) and aortic
graft-enteric fistula (n = 1). Eight patients (33%) under-
went a secondary surgical procedure.
Ten patients died in ICU. The mean length of ICU stay
for non survivors was 13.2 ± 9.5 days. Fourteen patients
were transferred from the ICU to medical or surgical
wards, 14 ± 12 days after ICU admission. Among them, one
patient died before hospital discharge. The in-hospital mor-
tality rate was thus 48% (12/25). Comparison of pre-
operative, intra-operative and post-operative patients’ char-
acteristics between in-hospital survivors and non survivors
is reported Table 4. Among pre-operative characteristics,
age ≥ 70 years, creatinine ≥ 12 mg/L and C reactive pro-
tein ≥ 50 mg/L were significantly associated with in-hospital
mortality. According to the number of these factors present
on ICU admission, in hospital mortality rates were 0%,
14.3%, 85.7% and 100% for 0, 1, 2 and 3 factors, respect-
ively. Interestingly, among the 12 patients < 70 years, only
one patient died during hospital stay and he had pre-
operative 13 mg/l creatinine and 235 mg/L C Reactive pro-
tein. Among the 13 patients, older than 70 years, 11 died
during hospital stay. The 2 survivors had neither creatin-
ine ≥ 12 mg/L nor C reactive protein ≥ 50 mg/L. Among in-
traoperative characteristics, only an associated intestinal
procedure was associated with prognosis. Finally, among
post-operative characteristics, non survivors had higher
SAPS II and SOFA Score on ICU admission and exhibited
more frequent medical and/or surgical complications.
One year after hospital discharge, all patients were still
alive without recurrence of infection.
Discussion
Twenty five patients suffering from intra-abdominal aor-
tic graft infection were included in this retrospective
study. All underwent graft excision. In-hospital morbid-
ity and mortality were high. Prognostic analysis suggests
that some characteristics of patients on hospital admis-
sion such as age and values of C-reactive protein and
creatinine could predict in-hospital outcome.
In our series, postoperative complications occurred in
67% of patients and 48% of patients died during hospital
stay. This mortality rate is in the high range on what is
reported in the literature with mortality rates for aortic
graft infection between 8 and 56.5% [17-27]. Most pub-
lished studies focused on surgical aspect of aortic graft
infection treatment but only few reported exhaustive
data on surgical patients underlying conditions. Finally,
search for predictive factors of perioperative mortality
was not performed in most studies.
In 2004, Kieffer et al. reported a series of 179 consecutive
surgery patients, from 1988 to 2002, and observed a 20.1%
early postoperative mortality [22]. Batt among 82 consecu-
tive aortic graft infection patients, from 2000 to 2008, found
a 33% perioperative mortality rate [6]. The same author
had reported in 2003 a lower perioperative death rate of
16.6% [21]. In our opinion, such discrepancies could only
be explained by differences between patients undergoing




SAPS II 47 ± 16
SOFA Score 8 ± 4
Mechanical ventilation 23 (92%)
Use of vasopressor(s) 13 (54%)
Biological data
Creatinine (mg/L) 14.1 ± 11.6
Lactate (mmol/L) 3.0 ± 2.5
C Reactive Protein (mg/L) 123 ± 84
PaO2/FiO2 (mmHg) 315 ± 155
During ICU stay
Occurrence of medical complications 16 (67%)
Occurrence of surgical complications 15 (63%)
Number of days without mechanical ventilation at D28* 10.3 ± 10.6
Number of days without use of vasopressors at D28* 15.5 ± 11.3
Number of days without renal replacement therapy at D28* 7.3 ± 9.9
Data are expressed as mean ± standard deviation values or numbers (%) of
patients. *Determined in patients treated with mechanical ventilation,
vasopressors and/or renal replacement therapy.
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surgical procedures, particularly underlying diseases. In the
2003 Batt’s study with 16.6% mortality, coronary artery dis-
ease, hypertension, diabetes mellitus, chronic obstructive
pulmonary disease, were found in 36%, 41%, 14%, and 22%
of patients, respectively [21]. In our series, the incidence of
these underlying diseases was quite higher since it was 64%,
72%, 16%, and 28%, respectively and this might explain the
differences in prognosis.
Table 4 Bivariate analysis of factors associated with in-hospital death
Variables Survivors (n = 13) Non survivors (n = 12) p
Pre-operative characteristics
Age (years) 61.6 ± 6.5 74.5 ± 3.5 0.0006
Age≥ 70 years 2 11 0.0002
Obesity (BMI > 30 kg/m2) 4 7 0.43
Hypertension 9 9 1
Coronary artery disease 9 7 0.69
Diabetes mellitus 3 1 0.6
COPD 5 2 0.39
Immunosuppression 3 3 1
ASA Score 2.9 ± 0.76 3.5 ± 0.67 0.09
Possum Score 42 ± 44 46 ± 55 0.06
Preoperative severe sepsis 2 5 0.20
Creatinine (mg/L) 10.4 ± 4.6 20.1 ± 18.4 0.03
Creatinine≥ 12 mg/L 3 9 0.02
C Reactive Protein (mg/L) 16.0 ± 26.0 126.5 ± 202.0 0.006
C Reactive Protein≥ 50 mg/L 2 8 0.008
Intra-operative characteristics
Emergent surgical procedure for anastomotic rupture 2 6 0.1
Mean duration of operation (minutes) 273 ± 70 266 ± 95 0.70
Mean duration of aortic clamping (minutes) 103 ± 39 136 ± 57 0.15
Suprarenal aortic clamping 2 4 0.36
Associated intestinal procedure 0 4 0.04
Number of packed red cells units 5.3 ± 1.2 6.1 ± 2.8 0.51
Volume of intra-operative colloid administration (ml) 961 ± 518 1083 ± 596 0.61
Volume of intra-operative crystalloid administration (ml) 4003 ± 924 3454 ± 1571 0.33
Use of vasopressor(s) 9 11 0.32
Post-operative characteristics
SAPS II on ICU admission 40.5 ± 8.2 54.7 ± 20.6 0.10
SOFA Score on ICU admission 6.5 ± 3.7 10.4 ± 3.9 0.05
Mechanical ventilation on ICU admission 12 11 1
Use of vasopressor(s) on ICU admission 5 8 0.12
Biological data on ICU admission
Creatinine (mg/L) 11.2 ± 4.4 17.5 ± 16.2 0.25
Lactate (mmol/L) 2.1 ± 0.7 4.0 ± 3.5 0.10
C Reactive Protein (mg/L) 106.6 ± 74.0 142.3 ± 97.0 0.70
PaO2/FiO2 (mmHg) 365.3 ± 137.1 260.1 ± 160.7 0.10
Occurrence of medical complications during ICU stay 6 10 0.02
Occurrence of surgical complications during ICU stay 5 10 0.01
Renal replacement therapy during ICU stay 4 8 0.16
Data are expressed as mean ± standard deviation values or numbers (%) of patients.
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Prognostic factors associated with early postoperative
mortality reported by Kieffer et al. were septic shock,
presence of aorto-enteric fistula, emergency surgery,
emergency allograft replacement, surgical or medical
complications, and need for repeat surgery [22]. In our
study we searched for pre, intra or post operative factors
associated with in-hospital mortality. Among postopera-
tive factors, occurrence of medical or surgical complica-
tions was associated with poor outcome, as in Kieffer’s
study. SOFA score on ICU admission was also signifi-
cantly higher in non survivors than in survivors. This
score reflects organ failures occurring during surgery
whereas septic shock reported by Kieffer fits only to
hemodynamic failure. The single intra operative cha-
racteristic associated with prognosis was “associated in-
testinal procedure”. This is similar to the presence of
aorto-enteric fistula previously reported. Surprisingly,
durations of operation and aortic clamping, suprarenal
clamping, volume of colloid or crystalloid administra-
tion, number of packed red cell units and vasopressors
use were not statistically different in survivors and non
survivors. Finally, we found that three preoperative fac-
tors, age ≥ 70 years, creatinine ≥ 12 mg/L, and C reactive
protein ≥ 50 mg/L were associated with prognosis. The
combination of these 3 prognostic factors seems inte-
resting since in hospital mortality rate was 7.7% when
no or only one factor was present and 91.6% when two
or three factors were present. An age under 70 years
could be a useful single factor to take in account as
91.6% of patients less than 70 years survived. Conversely,
the survival rate of patients over 70 years was very low
(15.4%). The survivors among the older patients had
neither creatinine ≥ 12 mg/L nor C reactive protein
≥ 50 mg/L. In our mind these data could be considered
before any surgical approach of an aortic graft infection.
A surgical procedure in older patients with either cre-
atinine ≥ 12 mg/L or C reactive protein ≥ 50 mg/L or
both could be questionable. Long-term or lifelong sup-
pressive antimicrobial therapy in patients who are not
eligible for surgical device removal has been reported
[28,29] with partial success. Medical treatment could ap-
pear as the best choice in patients for which graft exci-
sion is associated with no, or very low in-hospital
survival rate.
Our study has numerous limits. First of all, it is retro-
spective and performed in a single centre. Although data
collection was retrospective, it was exhaustive and only
one patient was excluded for lack of data. Second, the
number of included patients is low with only 25 studied
patients. Nevertheless, the number of patients included
in numerous other studies is similar [17,18,21,24,26]. Fi-
nally, the value of our statistical analysis is limited as no
multivariate analysis was performed. As underlined by
Peduzzi and Concato, logistic regression analysis needs
between 10 and 15 events per co variable [30]. As we
observed 12 events (in-hospital deaths) in this series, no
multivariate analysis could be performed. Nevertheless,
as data about prognostic factors are scarce, we believe
our results and particularly the impact of preoperative
factors such as age, and values of C reactive protein and
creatinine add to the knowledge of this disease. Ob-
viously, our results must be evaluated in a prospective
and, ideally, multicenter study including more patients.
Conclusion
In conclusion, morbidity and mortality associated with
surgical approach of aortic graft infections are consider-
able. Age and values of creatinine and C Reactive protein
on hospital admission appear as the most important de-
terminant of in hospital mortality and, consequently, of
surgical strategy.
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